These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36908664)

  • 1. Liraglutide Lowers Endothelial Vascular Cell Adhesion Molecule-1 in Murine Atherosclerosis Independent of Glucose Levels.
    Punjabi M; Kosareva A; Xu L; Ochoa-Espinosa A; Decembrini S; Hofmann G; Wyttenbach S; Rolin B; Nyberg M; Kaufmann BA
    JACC Basic Transl Sci; 2023 Feb; 8(2):189-200. PubMed ID: 36908664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.
    Gaspari T; Liu H; Welungoda I; Hu Y; Widdop RE; Knudsen LB; Simpson RW; Dear AE
    Diab Vasc Dis Res; 2011 Apr; 8(2):117-24. PubMed ID: 21562063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinomenine protects against atherosclerosis in apolipoprotein E-knockout mice by inhibiting of inflammatory pathway.
    Gao Z; Yang C; Zeng G; Lin M; Li W; Sun M; Zhang Y; Fan B; Kumar Y; Yan K
    Inflammopharmacology; 2024 Apr; 32(2):1387-1400. PubMed ID: 38430414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound Molecular Imaging of Atherosclerosis With Nanobodies: Translatable Microbubble Targeting Murine and Human VCAM (Vascular Cell Adhesion Molecule) 1.
    Punjabi M; Xu L; Ochoa-Espinosa A; Kosareva A; Wolff T; Murtaja A; Broisat A; Devoogdt N; Kaufmann BA
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2520-2530. PubMed ID: 31597443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis.
    Maiseyeu A; Di L; Ravodina A; Barajas-Espinosa A; Sakamoto A; Chaplin A; Zhong J; Gao H; Mignery M; Narula N; Finn AV; Rajagopalan S
    Theranostics; 2022; 12(6):2741-2757. PubMed ID: 35401813
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-atherosclerosis of oligomeric proanthocyanidins from Rhodiola rosea on rat model via hypolipemic, antioxidant, anti-inflammatory activities together with regulation of endothelial function.
    Zhou Q; Han X; Li R; Zhao W; Bai B; Yan C; Dong X
    Phytomedicine; 2018 Dec; 51():171-180. PubMed ID: 30466614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood of Patients With Coronary Heart Disease.
    Guo F; Sha Y; Hu B; Li G
    Front Cardiovasc Med; 2021; 8():682959. PubMed ID: 34235188
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of atherosclerosis.
    Chang W; Zhu F; Zheng H; Zhou Z; Miao P; Zhao L; Mao Z
    Mol Immunol; 2019 Dec; 116():73-79. PubMed ID: 31630078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE
    Rakipovski G; Rolin B; Nøhr J; Klewe I; Frederiksen KS; Augustin R; Hecksher-Sørensen J; Ingvorsen C; Polex-Wolf J; Knudsen LB
    JACC Basic Transl Sci; 2018 Dec; 3(6):844-857. PubMed ID: 30623143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties.
    Khanicheh E; Qi Y; Xie A; Mitterhuber M; Xu L; Mochizuki M; Daali Y; Jaquet V; Krause KH; Ruggeri ZM; Kuster GM; Lindner JR; Kaufmann BA
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2187-92. PubMed ID: 23908248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis.
    Khanicheh E; Mitterhuber M; Xu L; Haeuselmann SP; Kuster GM; Kaufmann BA
    PLoS One; 2013; 8(3):e58761. PubMed ID: 23554922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis.
    Tashiro Y; Sato K; Watanabe T; Nohtomi K; Terasaki M; Nagashima M; Hirano T
    Peptides; 2014 Apr; 54():19-26. PubMed ID: 24418070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GLP-1 receptor agonist liraglutide protects against oxidized LDL-induced endothelial inflammation and dysfunction via KLF2.
    Yue W; Li Y; Ou D; Yang Q
    IUBMB Life; 2019 Sep; 71(9):1347-1354. PubMed ID: 30969479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators.
    Bruen R; Curley S; Kajani S; Lynch G; O'Reilly ME; Dillon ET; Brennan EP; Barry M; Sheehan S; McGillicuddy FC; Belton O
    J Pharmacol Exp Ther; 2019 Sep; 370(3):447-458. PubMed ID: 31270216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal.
    Sun C; Alkhoury K; Wang YI; Foster GA; Radecke CE; Tam K; Edwards CM; Facciotti MT; Armstrong EJ; Knowlton AA; Newman JW; Passerini AG; Simon SI
    Circ Res; 2012 Sep; 111(8):1054-64. PubMed ID: 22874466
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.